Bank of New York Mellon’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-282,907
Closed -$5.7M 4673
2021
Q3
$5.7M Sell
282,907
-26,396
-9% -$532K ﹤0.01% 2418
2021
Q2
$11.5M Buy
309,303
+44,329
+17% +$1.65M ﹤0.01% 2048
2021
Q1
$6.78M Sell
264,974
-13,624
-5% -$348K ﹤0.01% 2298
2020
Q4
$6.14M Buy
278,598
+2,057
+0.7% +$45.3K ﹤0.01% 2258
2020
Q3
$4.97M Sell
276,541
-12,738
-4% -$229K ﹤0.01% 2220
2020
Q2
$7.35M Buy
289,279
+38,893
+16% +$988K ﹤0.01% 2004
2020
Q1
$4.6M Sell
250,386
-42,068
-14% -$773K ﹤0.01% 2111
2019
Q4
$6.44M Buy
292,454
+81,638
+39% +$1.8M ﹤0.01% 2210
2019
Q3
$3.03M Sell
210,816
-6,098
-3% -$87.6K ﹤0.01% 2525
2019
Q2
$3.42M Sell
216,914
-2,016
-0.9% -$31.7K ﹤0.01% 2517
2019
Q1
$3.21M Buy
218,930
+837
+0.4% +$12.3K ﹤0.01% 2543
2018
Q4
$2.33M Buy
218,093
+32,652
+18% +$349K ﹤0.01% 2650
2018
Q3
$2.83M Buy
185,441
+24,543
+15% +$375K ﹤0.01% 2668
2018
Q2
$1.97M Buy
160,898
+119,466
+288% +$1.46M ﹤0.01% 2846
2018
Q1
$397K Buy
41,432
+21,853
+112% +$209K ﹤0.01% 3674
2017
Q4
$177K Sell
19,579
-8,985
-31% -$81.2K ﹤0.01% 3961
2017
Q3
$164K Hold
28,564
﹤0.01% 3915
2017
Q2
$91K Sell
28,564
-555
-2% -$1.77K ﹤0.01% 4046
2017
Q1
$99K Buy
29,119
+350
+1% +$1.19K ﹤0.01% 4029
2016
Q4
$83K Buy
28,769
+12,111
+73% +$34.9K ﹤0.01% 4053
2016
Q3
$98K Sell
16,658
-2,841
-15% -$16.7K ﹤0.01% 4047
2016
Q2
$58K Sell
19,499
-35,030
-64% -$104K ﹤0.01% 4153
2016
Q1
$292K Sell
54,529
-3,440
-6% -$18.4K ﹤0.01% 3652
2015
Q4
$688K Sell
57,969
-10,862
-16% -$129K ﹤0.01% 3376
2015
Q3
$566K Buy
68,831
+10,455
+18% +$86K ﹤0.01% 3500
2015
Q2
$814K Buy
58,376
+29,758
+104% +$415K ﹤0.01% 3446
2015
Q1
$688K Buy
28,618
+1,030
+4% +$24.8K ﹤0.01% 3479
2014
Q4
$454K Buy
27,588
+3,868
+16% +$63.7K ﹤0.01% 3659
2014
Q3
$302K Sell
23,720
-46
-0.2% -$586 ﹤0.01% 3776
2014
Q2
$537K Buy
23,766
+15,410
+184% +$348K ﹤0.01% 3587
2014
Q1
$236K Buy
+8,356
New +$236K ﹤0.01% 3789